Identification of Fungus-Derived Natural Products as New Antigiardial Scaffolds-Reference-Cited by-同舟云学术

Identification of Fungus-Derived Natural Products as New Antigiardial Scaffolds

Published:2023-06-15 Issue:3 Volume:11 Page:
ISSN:2165-0497
Container-title:Microbiology Spectrum
language:en
Short-container-title:Microbiol Spectr

Author:

Hulverson Matthew A.¹^ORCID,Michaels Samantha A.¹,Lee Jin Woo²,Wendt Karen L.³,Tran Linh T.¹,Choi Ryan¹,Van Voorhis Wesley C.¹,Cichewicz Robert H.³,Ojo Kayode K.¹^ORCID

Affiliation:

1. Department of Medicine, Division of Allergy and Infectious Diseases, Center for Emerging and Reemerging Infectious Diseases (CERID), University of Washington, Seattle, Washington, USA

2. College of Pharmacy, Duksung Women’s University, Seoul, Republic of Korea

3. Natural Products Discovery Group, Institute for Natural Products Applications and Research Technologies, Department of Chemistry and Biochemistry, Stephenson Life Sciences Research Center, University of Oklahoma, Norman, Oklahoma, USA

Abstract

There is a direct link between widespread prevalence of clinical giardiasis and poverty. This may be one of the reasons why giardiasis is a significant contributor to diarrheal morbidity, stunting, and death of children in resource-limited communities around the world.

Funder

HHS | NIH | National Institute of Allergy and Infectious Diseases

Washington Research Foundation

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

Link

https://journals.asm.org/doi/pdf/10.1128/spectrum.00647-23

Reference25 articles.

1. Pathogen-specific burdens of community diarrhoea in developing countries: a multisite birth cohort study (MAL-ED)

2. A Prospective Longitudinal Cohort to Investigate the Effects of Early Life Giardiasis on Growth and All Cause Diarrhea

3. Increased incidence of nitroimidazole-refractory giardiasis at the Hospital for Tropical Diseases, London: 2008–2013

4. New approaches to the treatment of giardiasis

5. Giardiasis in the Post Genomic Era: Treatment, Drug Resistance and Novel Therapeutic Perspectives